Lactulose Is Associated With Decreased Risk of Clostridium difficile Infection in Decompensated Cirrhosis
- 1 June 2017
- journal article
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 15 (6) , 953-954
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Fecal Microbiota Transplantation for Clostridium difficile InfectionAnnals of Internal Medicine, 2015
- Prebiotic-non-digestible oligosaccharides preference of probiotic bifidobacteria and antimicrobial activity against Clostridium difficileAnaerobe, 2012
- Validation of three coding algorithms to identify patients with end‐stage liver disease in an administrative databasePharmacoepidemiology and Drug Safety, 2012
- Clostridium difficile— More Difficult Than EverNew England Journal of Medicine, 2008
- Effect of the Prebiotic Oligofructose on Relapse of Clostridium difficile-Associated Diarrhea: A Randomized, Controlled StudyClinical Gastroenterology and Hepatology, 2005
- Effect of lactulose on short-chain fatty acids and lactate production and on the growth of faecal flora, with special reference to Clostridium difficileJournal of Medical Microbiology, 1997